Literature DB >> 24820929

Thromboembolic stroke after cardioversion with incomplete left atrial appendage closure.

Koji Hanazawa1, Michele Brunelli, J Christoph Geller.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24820929     DOI: 10.1007/s00392-014-0724-0

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  9 in total

1.  Left atrial appendage occlusion in valvular atrial fibrillation following MitraClip implantation.

Authors:  Alexander Jabs; Ulrich Hink; Ascan Warnholtz; Ralph Stephan von Bardeleben; Philipp Nikolai; Thomas Münzel; Tommaso Gori
Journal:  Clin Res Cardiol       Date:  2012-05       Impact factor: 5.460

2.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

Authors:  Stefan H Ostermayer; Mark Reisman; Paul H Kramer; Ray V Matthews; William A Gray; Peter C Block; Heyder Omran; Antonio L Bartorelli; Paolo Della Bella; Carlo Di Mario; Carlo Pappone; Paul N Casale; Jeffrey W Moses; Athena Poppas; David O Williams; Bernhard Meier; Allan Skanes; Paul S Teirstein; Michael D Lesh; Toshiko Nakai; Yves Bayard; Kai Billinger; Thomas Trepels; Ulrike Krumsdorf; Horst Sievert
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

3.  The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.

Authors:  Juan F Viles-Gonzalez; Saibal Kar; Pamela Douglas; Srinivas Dukkipati; Ted Feldman; Rodney Horton; David Holmes; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2012-03-06       Impact factor: 24.094

4.  Left atrial appendage closure in a patient with atrial fibrillation after mechanical mitral valve replacement and cardio-embolic stroke despite effective oral anticoagulant therapy: a case report.

Authors:  Alexander Sedaghat; Georg Nickenig; Christoph Hammerstingl
Journal:  Clin Res Cardiol       Date:  2014-04-01       Impact factor: 5.460

5.  Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience.

Authors:  Yat-Yin Lam; Gabriel W K Yip; Cheuk-Man Yu; Wilson W M Chan; Boron C W Cheng; Bryan P Yan; Richard Clugston; Gerald Yong; Tim Gattorna; Vincent Paul
Journal:  Catheter Cardiovasc Interv       Date:  2011-11-30       Impact factor: 2.692

6.  Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience.

Authors:  Jai-Wun Park; Armando Bethencourt; Horst Sievert; Gennaro Santoro; Bernhard Meier; Kevin Walsh; Jose Ramon Lopez-Minguez; Jose Ramon Lopez-Minquez; David Meerkin; Mariano Valdés; Oliver Ormerod; Boris Leithäuser
Journal:  Catheter Cardiovasc Interv       Date:  2011-03-08       Impact factor: 2.692

7.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

8.  Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation.

Authors:  Bernhard Meier; Igor Palacios; Stephan Windecker; Martin Rotter; Qi-Ling Cao; David Keane; Carlos E Ruiz; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2003-11       Impact factor: 2.692

9.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

  9 in total
  7 in total

1.  Percutaneous management of periprocedural cardiac perforation during left atrial appendage closure.

Authors:  Nico Reinsch; Hagen Kälsch; Philipp Kahlert
Journal:  Clin Res Cardiol       Date:  2015-11-26       Impact factor: 5.460

2.  Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.

Authors:  Julia Seeger; Carlo Bothner; Tillman Dahme; Birgid Gonska; Dominik Scharnbeck; Sinisa Markovic; Wolfgang Rottbauer; Jochen Wöhrle
Journal:  Clin Res Cardiol       Date:  2015-08-30       Impact factor: 5.460

3.  Safety of percutaneous coronary intervention in patients with acute ischemic stroke/transient ischemic attack and acute coronary syndrome.

Authors:  Tobias Zeus; Ulrike Ketterer; Daniela Leuf; Lisa Dannenberg; Florian Bönner; Rabea Wagstaff; Michael Gliem; Sebastian Jander; Malte Kelm; Amin Polzin
Journal:  Clin Res Cardiol       Date:  2015-10-29       Impact factor: 5.460

4.  Percutaneous closure of an incomplete left atrial appendage closure.

Authors:  Manuel Viehmann; Ingo Dähnert; Gerhard Schuler; Marcus Sandri
Journal:  Clin Res Cardiol       Date:  2016-04-01       Impact factor: 5.460

Review 5.  Incomplete Closure of the Left Atrial Appendage: Implication and Management.

Authors:  Arash Aryana; André d'Avila
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

Review 6.  Optimization Of Stroke Prophylaxis Strategies In Nonvalvular AF -Drugs, Devices Or Both?

Authors:  Amit Noheria; Faisal F Syed; Christopher V DeSimone; Samuel J Asirvatham
Journal:  J Atr Fibrillation       Date:  2015-08-31

Review 7.  Cardioversion in Non-Valvular Atrial Fibrillation.

Authors:  Hermann H Klein; Hans-Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2015-12-11       Impact factor: 5.594

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.